Our results suggested the possibility that the overexpression of ARPC1B promoted the expression of cell proliferation or metastasis-related proteins by the activation of the Wnt/β-Catenin signaling pathway in ovarian cancer. This evidence concerns the gene ARPC1B and ovarian carcinoma.